Screening for Atrial Fibrillation by Digital Health Technology in Older People in Homecare Settings: A Feasibility Trial

Table 1

Clinical characteristics of the study population, .

Women (%)	9 (50)
Mean age (years) (SD)	81 (7)
Mean body mass index (kg/m^2) (SD)	27 (6)
Smoking (%)	1 (8)
Hypertension (%)	10 (78)
Diabetes (%)	6 (46)
Previous coronary heart disease
Myocardial infarction (%)	2 (15)
Percutaneous coronary intervention (%)	3 (23)
Coronary artery bypass grafting (%)	2 (15)
Previous stroke (%)	2 (15)
Peripheral artery disease (%)	0 (0)
Heart failure (%)	2 (15)
Hypothyroidism (%)	3 (23)
Hyperthyroidism (%)	0 (0)
Chronic obstructive pulmonary disease (%)	1 (8)
Sleep apnoea (%)	1 (8)
Mean CHA2DS2-VASc risk score (SD)	3.7 (1.4)
Median CHA2DS2-VASc risk score (IQR)	3 (3-4)
Medication use
Acetylsalicylic acid (%)	9 (69)
Anticoagulation therapy (%)	0 (0)
Lipid-lowering therapy (%)	12 (92)
Beta blocker (%)	6 (46)
Angiotensin-converting enzyme (ACE) inhibitors (%)	3 (23)
Angiotensin II receptor blockers (%)	8 (62)

SD: standard deviation; IQR: interquartile range; CHA₂DS₂-VASc: congestive heart failure, hypertension, years (doubled), diabetes, stroke (doubled), vascular disease, age 65 to 74 years and sex category (female).